These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31382984)

  • 1. Excluding the ischiorectal fossa irradiation during neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy followed by abdominoperineal resection decreases perineal complications in patients with lower rectal cancer.
    Song M; Geng J; Wang L; Li Y; Zhu X; Li X; Mi L; Wu A; Peng Y; Yao Y; Zhang Y; Wang H; Shi C; Cai Y; Wang W
    Radiat Oncol; 2019 Aug; 14(1):138. PubMed ID: 31382984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.
    Wang L; Li ZY; Li ZW; Li YH; Sun YS; Ji JF; Gu J; Cai Y
    Dis Colon Rectum; 2015 Feb; 58(2):186-92. PubMed ID: 25585076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominoperineal resection for rectal cancer at a specialty center.
    Nissan A; Guillem JG; Paty PB; Douglas Wong W; Minsky B; Saltz L; Cohen AM
    Dis Colon Rectum; 2001 Jan; 44(1):27-35; discussion 35-6. PubMed ID: 11805560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002).
    Wang J; Guan Y; Gu W; Yan S; Zhou J; Huang D; Tong T; Li C; Cai S; Zhang Z; Zhu J
    Radiat Oncol; 2019 Nov; 14(1):215. PubMed ID: 31783766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does one size fit all? Risks and benefits of neoadjuvant chemoradiation in patients with clinical stage IIA rectal cancer requiring abdominoperineal resection.
    de Camargo MGM; Xhaja X; Aiello A; Liska D; Gorgun E; Dietz DW; Kalady MF; Delaney CP; Steele SR; Valente MA
    Am J Surg; 2020 Mar; 219(3):406-410. PubMed ID: 31672306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study.
    Gérard JP; Barbet N; Gal J; Dejean C; Evesque L; Doyen J; Coquard R; Gugenheim J; Benizri E; Schiappa R; Baudin G; Benezery K; François E
    Eur J Cancer; 2019 Feb; 108():1-16. PubMed ID: 30580125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns.
    Yamamoto T; Kawada K; Hida K; Ganeko R; Inamoto S; Yoshitomi M; Watanabe T; Sakai Y
    Int J Clin Oncol; 2019 Jun; 24(6):677-685. PubMed ID: 30721379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of oncological outcomes after abdominoperineal excision before and after the implementation of a selective perineal flap closure program.
    Murphy C; Stephens I; OꞌFlanagan G; OꞌByrne L; Reynolds IS; Ajmal N; O'Sullivan JB; OꞌNeill B; Deasy J; Burke JP; McNamara DA
    J Surg Oncol; 2021 Feb; 123(2):614-621. PubMed ID: 33238062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of neoadjuvant chemoradiotherapy on peritoneal wound healing after abdominoperineal resection].
    Wang G; Yao X; Wu YJ; Tao KX; Gao JB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jun; 27(6):615-620. PubMed ID: 38901995
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: retrospective case series.
    Souadka A; Majbar MA; Benkabbou A; Serji B; Souiki T; Bouchentouf SM; Abid M; El Khannousi B; El Harroudi T; El Malki HO; Raiss M; Ifrine L; Mazaz K; Zentar A; Mohsine R; Souadka A; Belkouchi A; Ahallat M; Hrora A;
    BMC Cancer; 2019 Oct; 19(1):1008. PubMed ID: 31660903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perineal wound healing after abdominoperineal resection for rectal cancer: a two-centre experience in the era of intensified oncological treatment.
    Musters GD; Sloothaak DA; Roodbeen S; van Geloven AA; Bemelman WA; Tanis PJ
    Int J Colorectal Dis; 2014 Sep; 29(9):1151-7. PubMed ID: 25064389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of a nomogram predicting risk factors of postoperative perineal wound complications after abdominoperineal resection for rectal cancer].
    Lu SQ; Chang XF; Yang XD; Yu DC; Huang QG; Wang F
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):357-363. PubMed ID: 31054550
    [No Abstract]   [Full Text] [Related]  

  • 16. "Watch and wait" approach in rectal cancer patients following complete clinical response to neoadjuvant chemoradiotherapy does not compromise oncologic outcomes.
    Neşşar G; Demirbağ AE; Mısırlıoğlu HC; Sezer S
    Turk J Gastroenterol; 2019 Nov; 30(11):951-956. PubMed ID: 31767549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability, Safety, and Outcomes of Neoadjuvant Chemoradiotherapy With Capecitabine for Patients Aged ≥ 70 Years With Locally Advanced Rectal Cancer.
    Jacobs L; van der Vlies E; Ten Bokkel Huinink D; Bloemendal H; Intven M; Smits AB; Weusten BLAM; Siersema PD; van Lelyveld N; Los M
    Clin Colorectal Cancer; 2018 Sep; 17(3):179-186. PubMed ID: 29661620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience.
    Nguyen P; Wuthrick E; Chablani P; Robinson A; Simmons L; Wu C; Arnold M; Harzman AE; Husain S; Schmidt C; Abdel-Misih S; Bekaii-Saab T; Chakravarti A; Williams TM
    Am J Clin Oncol; 2018 Feb; 41(2):140-146. PubMed ID: 26535992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective controlled study of the safety and oncological outcomes of ELAPE procure with definitive anatomic landmarks versus conventional APE for lower rectal cancer.
    Shen Z; Ye Y; Zhang X; Xie Q; Yin M; Yang X; Jiang K; Liang B; Wang S
    Eur J Surg Oncol; 2015 Apr; 41(4):472-7. PubMed ID: 25659773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].
    Li YH; Qiu XY; Lin GL; Zhou JL; Xiao Y; Qiu HZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):344-351. PubMed ID: 33878824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.